A personal choice test by individuals wishing to know if they have contracted the virus.
JoysBio Biotechnology Co’s , SARS-CoV-2 Antigen Rapid Test Kit is capable of detecting the new coronavirus strain found referred to as SARS-CoV-2 VUI 202012/01, Variant of Concern 202012/01, VOC-202012/01, or lineage B.1.1.7, was identified first in the UK during the autumn of 2020, and later in France and the US as well.
SARS-CoV-2 VUI 202012/01 is believed to be a more contagious strain than other variants of COVID-19
Detection specificity is 98.13%, and the sensitivity is 99.22%.
In use daily use throughout Europe, (Antigen testing, recently adopted by haulers detained in the UK or traveling out of Irish ports as a precondition before allowing entry to Europe)
JoysBio Rapid Laterial Flow Antigen testing allows a quick solution to determine if you have contracted the COVID-19 virus.
Results in 20 minutes
All components are CE marked
ISO 13485 Standard, MDD-IVDD (EU 98/97 EC Directive)
Easy to use and read, with no specialist equipment required
Significant time and cost saving over lab methods
Screen individuals throughout the population as a personal choice, especially for industry, commercial work settings, and certain type of travel
Operates in conjunction with HEALTH PASSPORT EUROPE (free to download on the app stores)
ONLY AVAILABLE TO HEALTH CARE PROFESSIONALS i.e. GP’s and Pharmacies etc